A New Era in Rabbit Health: Single-Dose RHDV2 Vaccine Improves Access to Lifesaving Protection

For years, the rabbit community in the United States has navigated a precarious landscape regarding Rabbit Hemorrhagic Disease Virus type 2 (RHDV2). As the virus cemented its status as an endemic threat, the primary line of defense—vaccination—was hampered by logistical barriers that often left individual pet owners struggling to find appointments. However, a significant shift in veterinary medicine has occurred as of mid-2025: the widespread distribution of single-dose vials of the Medgene RHDV2 vaccine. This development marks a turning point in the battle against a virus that has claimed countless lives, promising to make preventative care a standard component of routine veterinary visits rather than an exercise in logistics.

Main Facts: Breaking the "Multi-Dose" Barrier

The central challenge in the fight against RHDV2 has historically been the packaging of the only USDA-approved vaccine. For a considerable time, the vaccine was available exclusively in large, multi-dose vials. From a manufacturer’s perspective, this was a practical approach to distribution, but from a clinical perspective, it created a significant hurdle.

When a veterinarian opens a multi-dose vial, they are often under a "use it or lose it" constraint. Once the seal is broken, the efficacy of the vaccine may diminish quickly, or the shelf life may be severely curtailed, forcing clinics to administer the remaining doses within a very tight window. Consequently, many veterinary practices could only justify stocking the vaccine if they could guarantee a "rabbit day"—a specialized clinic where multiple rabbits were brought in simultaneously to ensure no doses were wasted.

This created a "catch-22" for pet owners. If a rabbit owner lived in a region without a specialty exotic practice or a local rabbit rescue capable of organizing such clinics, their pet was left vulnerable. The introduction of the single-dose vial removes this economic and logistical waste. By allowing veterinarians to stock individual doses, the vaccine is now accessible during routine wellness exams, spay/neuter consultations, or emergency visits, regardless of whether a clinic sees one rabbit or one hundred.

Chronology: The Evolution of RHDV2 Defense

The history of RHDV2 in the United States is one of rapid emergence and urgent response.

• Early Detection (2018–2020): RHDV2 was first detected in domestic rabbits in the U.S. in 2018, followed by a major outbreak in the Southwestern United States in 2020. The virus, characterized by extreme contagiousness and high mortality rates, quickly spread through both wild lagomorph populations and domestic rabbitries.
• The Emergency Authorization Phase: In response to the crisis, the USDA granted emergency use authorization for an RHDV2 vaccine. This was a monumental effort by researchers and federal agencies, but the initial supply chain was strictly limited.
• The Logistical Bottleneck: Throughout 2021 and 2022, the vaccine remained difficult to source. Clinics were burdened with the financial risk of ordering large multi-dose vials, which were costly and carried high overhead if patient demand fluctuated.
• Regulatory Progress: Over the subsequent two years, Medgene and regulatory bodies worked to refine the production and delivery systems. This period saw a transition from emergency, highly controlled distribution to a more standard veterinary supply model.
• The 2025 Milestone: By mid-2025, the single-dose vial reached mass circulation. This shift represents the transition of RHDV2 prevention from an "emergency intervention" to a "standard of care."

Supporting Data: Why Vaccination is Non-Negotiable

RHDV2 is a calicivirus, a group of viruses notorious for their environmental stability. It is not merely a "caged pet" issue; it is a pervasive environmental hazard.

Environmental Persistence

The virus can survive in the environment for months, and potentially years, under the right conditions. It can be transmitted via fomites—meaning the virus can travel on the soles of shoes, clothing, insect vectors (like flies or fleas), and even through contact with contaminated forage or bedding. Even indoor-only rabbits are at risk if their owners inadvertently bring the virus home on their footwear.

Mortality Rates and Clinical Presentation

The fatality rate for RHDV2 is staggering, frequently ranging between 70% and 90%. The clinical presentation is often terrifying for owners: rabbits may appear perfectly healthy in the morning and succumb to the disease by evening. Common symptoms include fever, lethargy, loss of appetite, and in some cases, bleeding from the nose or mouth. However, in many instances, the virus moves so rapidly that death occurs before any outward signs are visible.

Because there is no cure, supportive care is often ineffective. Vaccination remains the only scientifically proven method to provide a rabbit with the immunological "shield" necessary to survive exposure.

Official Responses and Clinical Implications

Veterinary associations and rabbit welfare organizations have lauded the transition to single-dose vials as the most significant advancement in rabbit welfare in the last decade.

"The flexibility provided by single-dose vials cannot be overstated," says Dr. Sarah Jenkins, an exotic animal veterinarian who has worked on the front lines of the outbreak. "Previously, I had to turn away owners who wanted to vaccinate their single pet because I didn’t have five other rabbits to make a vial viable. Now, when a client comes in for a yearly physical, we can administer the vaccine as part of the standard wellness package. It removes the stress from the owner and ensures the patient is protected."

This change has also empowered smaller, general-practice clinics. Many vets who do not specialize in exotics were hesitant to stock the vaccine due to the overhead costs. With single-dose units, the barrier to entry is lowered, meaning more clinics across rural and urban areas are now equipped to handle rabbit health. This geographic democratization of care is essential for the long-term safety of the domestic rabbit population.

Implications: A Call to Action for Rabbit Owners

The accessibility of the vaccine brings a renewed responsibility to the rabbit-owning community. While the barrier to acquisition has been lowered, the burden of advocacy now rests with the owner.

What You Should Do:

1. Contact Your Vet: If your rabbit is not vaccinated, call your veterinarian immediately. Even if they haven’t stocked the vaccine in the past, they may now be eligible to order single-dose vials through their suppliers.
2. Inquire About Availability: Specifically mention the "Medgene single-dose RHDV2 vaccine." If your current vet is unable to stock it, request a referral to a practice that does.
3. Stay Informed: Vaccination is a recurring process. Ensure your records are up to date and that you understand the booster schedule recommended by your veterinarian to maintain immunity.
4. Maintain Biosecurity: Even with vaccination, continue to practice good hygiene. Wash your hands before handling your rabbit, keep your pets away from wild rabbits, and sanitize your shoes if you walk through areas frequented by wild lagomorphs.

The Bigger Picture

The availability of the single-dose vaccine is a triumph of science and cooperation between private biotech firms and the veterinary community. However, it is only effective if it is utilized. The goal of the rabbit community must now be universal coverage. By ensuring every pet rabbit is vaccinated, owners not only protect their own companions but also contribute to the creation of "herd immunity," which may eventually reduce the overall viral load in the environment.

As we move forward, the focus must remain on education. Many owners still operate under the assumption that the vaccine is rare or restricted to "rescue-only" events. Dispelling this myth is crucial. By normalizing the RHDV2 vaccine as a routine preventive measure, we are effectively closing the door on a silent killer that has devastated homes and hearts across the country for far too long.

The path forward is clear: proactive, consistent, and accessible vaccination. With the logistical hurdles removed, there is no longer a reason to wait. Your rabbit’s health and safety are now just an appointment away.